Literature DB >> 2606478

Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256----Val); PiMmalton (Phe51----deletion) and PiI (Arg39----Cys).

A Graham1, N A Kalsheker, C R Newton, F J Bamforth, S J Powell, A F Markham.   

Abstract

Three mutations causing alpha-1-antitrypsin deficiency have been identified by gene amplification and direct DNA sequencing. In the Pi (proteinase-inhibitor) nullcardiff gene, the codon for aspartate at position 256 has mutated to encode valine. In PiMmalton and Pi I, the respective mutations are the deletion of the codon for a phenylalanine residue at position 51 or 52, and a single base substitution resulting in arginine being replaced by cysteine at position 39. Examination of the protein tertiary structure suggests that all of these mutations are likely to result in folding abnormalities that may explain the deficiency states.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606478     DOI: 10.1007/bf00210671

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

1.  Leukocyte recruitment to airways by cigarette smoke and particle phase in contrast to cytotoxicity of vapor.

Authors:  K H Kilburn; W McKenzie
Journal:  Science       Date:  1975-08-22       Impact factor: 47.728

2.  Highly polymorphic minisatellite sequences: allele frequencies and mutation rates for five locus-specific probes in a Caucasian population.

Authors:  J C Smith; R Anwar; J Riley; D Jenner; A F Markham; A J Jeffreys
Journal:  J Forensic Sci Soc       Date:  1990 Jan-Feb

3.  The serpins: evolution and adaptation in a family of protease inhibitors.

Authors:  R W Carrell; P A Pemberton; D R Boswell
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1987

4.  Alpha 1 antitrypsin deficiency due to MMaltonZ phenotype: case report and family study.

Authors:  M B Allen; A M Ward; W H Perks
Journal:  Thorax       Date:  1986-07       Impact factor: 9.139

Review 5.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

6.  alpha 1-Antitrypsin nullGranite Falls, a nonexpressing alpha 1-antitrypsin gene associated with a frameshift to stop mutation in a coding exon.

Authors:  T Nukiwa; H Takahashi; M Brantly; M Courtney; R G Crystal
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

7.  Diagnosis of alpha 1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products.

Authors:  C R Newton; N Kalsheker; A Graham; S Powell; A Gammack; J Riley; A F Markham
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

8.  Alpha 1 antitrypsin deficiency due to Pi null: clinical presentation and evidence for molecular heterogeneity.

Authors:  F J Bamforth; N A Kalsheker
Journal:  J Med Genet       Date:  1988-02       Impact factor: 6.318

9.  Emphysema of early onset associated with a complete deficiency of alpha-1-antitrypsin (null homozygotes).

Authors:  D W Cox; H Levison
Journal:  Am Rev Respir Dis       Date:  1988-02

10.  Emphysema associated with complete absence of alpha 1- antitrypsin in serum and the homozygous inheritance [corrected] of a stop codon in an alpha 1-antitrypsin-coding exon.

Authors:  K Satoh; T Nukiwa; M Brantly; R I Garver; M Hofker; M Courtney; R G Crystal
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

View more
  18 in total

1.  Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) Null(Newport) (Gly115----Ser) and (Pi) Z Wrexham (Ser-19----Leu).

Authors:  A Graham; N A Kalsheker; F J Bamforth; C R Newton; A F Markham
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

Review 2.  Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease.

Authors:  N Kalsheker; K Morgan
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

3.  A novel alpha1-antitrypsin null variant (PiQ0Milano ).

Authors:  Raffaela Rametta; Gabriella Nebbia; Paola Dongiovanni; Marcello Farallo; Silvia Fargion; Luca Valenti
Journal:  World J Hepatol       Date:  2013-08-27

4.  Characterization of the molecular basis of the alpha 1-antitrypsin F allele.

Authors:  H Okayama; M Brantly; M Holmes; R G Crystal
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

5.  Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema.

Authors:  E Verpy; M Biasotto; M Brai; G Misiano; T Meo; M Tosi
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

6.  Transverse formamide gradients as a simple and easy way to optimise DNA single-strand conformation polymorphism analysis.

Authors:  B Paccoud; J Bourguignon; M Diarra-Mehrpour; J P Martin; R Sesboüé
Journal:  Nucleic Acids Res       Date:  1998-05-01       Impact factor: 16.971

7.  DNA polymorphisms associated with a new alpha 1-antitrypsin PIQ0 variant (PIQ0riedenburg).

Authors:  W Poller; J P Faber; S Weidinger; K Olek
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

8.  Highly variable clinical course in severe alpha 1-antitrypsin deficiency--use of polymerase chain reaction for the detection of rare deficiency alleles.

Authors:  W Poller; J P Faber; K Olek
Journal:  Klin Wochenschr       Date:  1990-09-03

9.  Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis.

Authors:  R Mahadeva; W S Chang; T R Dafforn; D J Oakley; R C Foreman; J Calvin; D G Wight; D A Lomas
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

10.  A null deficiency allele of alpha 1-antitrypsin, QOludwigshafen, with altered tertiary structure.

Authors:  G C Frazier; M A Siewertsen; M H Hofker; M G Brubacher; D W Cox
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.